Highlights of the second international conference on "immunotherapy in pediatric oncology"

Christian M. Capitini, Stephen Gottschalk, Malcolm Brenner, Laurence J.N. Cooper, Rupert Handgretinger, Crystal L. MacKall

Research output: Contribution to journalReview article

Abstract

The Second International Conference on Immunotherapy in Pediatric Oncology was held in Houston, Texas, USA, October 1112, 2010, to discuss the progress and challenges that have occurred in cutting edge immunotherapeutic strategies currently being developed for pediatric oncology. Major topics included immune targeting of acute lymphoblastic leukemia and pediatric solid tumors, chimeric antigen receptors (CARs) for hematologic malignancies and solid tumors, enhancing graft-versus-leukemia for pediatric cancers, overcoming hurdles of immunotherapy, strategies to active the innate immune system, and moving immunotherapy beyond phase I studies. Significant progress has been made in the last 2 years both in the development of novel immunobiologics such as CARs, and in establishing survival benefits of an anti-GD2 monoclonal antibody in randomized studies. Although there is much excitement going forward, a great deal of laboratory and regulatory challenges lie ahead in improving the efficacy of each of these modalities as well as getting them to patients in a timely and cost-effective fashion. The resulting discussions will hopefully lead to new collaborations and insight for further translational and clinical studies.

Original languageEnglish (US)
Pages (from-to)459-460
Number of pages2
JournalPediatric Hematology and Oncology
Volume28
Issue number6
DOIs
StatePublished - Sep 1 2011

Keywords

  • HSCT
  • immunology
  • immunotherapy
  • oncology (target therapy)
  • phase I/II studies

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Highlights of the second international conference on "immunotherapy in pediatric oncology"'. Together they form a unique fingerprint.

  • Cite this

    Capitini, C. M., Gottschalk, S., Brenner, M., Cooper, L. J. N., Handgretinger, R., & MacKall, C. L. (2011). Highlights of the second international conference on "immunotherapy in pediatric oncology". Pediatric Hematology and Oncology, 28(6), 459-460. https://doi.org/10.3109/08880018.2011.596615